Loading institutional data...
Loading institutional data...
Held by 263 of 5,944 reporting institutions (93th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -44%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $91M covers all $30M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2014-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~2.6% on $310M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.01B 100.0% | $940.2M 100.0% | $747.7M 100.0% | $801.2M 100.0% | $702.8M 100.0% | $498.8M 100.0% | $362.3M 100.0% | $183.9M 100.0% | $107.6M 100.0% | $84.2M 100.0% |
| Cost of Revenue | $468.7M 46.2% | $450.6M 47.9% | $380.0M 50.8% | $388.2M 48.5% | $326.6M 46.5% | $238.3M 47.8% | $168.1M 46.4% | $94.0M 51.1% | $63.5M 59.0% | $60.7M 72.0% |
| Gross Profit | $546.0M 53.8% | $489.6M 52.1% | $367.7M 49.2% | $413.0M 51.5% | $376.2M 53.5% | $260.5M 52.2% | $194.2M 53.6% | $89.8M 48.9% | $44.1M 41.0% | $23.6M 28.0% |
| Research & Development | — | — | — | — | $92.1M 13.1% | $63.6M 12.7% | $45.2M 12.5% | $29.2M 15.9% | $20.7M 19.2% | $18.8M 22.3% |
| Selling, General & Admin | $445.0M 43.9% | $389.8M 41.5% | $352.5M 47.1% | $335.7M 41.9% | $261.5M 37.2% | $204.9M 41.1% | $165.7M 45.7% | $105.2M 57.2% | $86.4M 80.3% | $82.8M 98.3% |
| Total Operating Expenses | $733.3M 72.3% | $588.7M 62.6% | $600.9M 80.4% | $505.8M 63.1% | $353.6M 50.3% | $268.5M 53.8% | $210.9M 58.2% | $134.5M 73.1% | $107.0M 99.5% | $101.6M 120.6% |
| Operating Income | -$187.3M -18.5% | -$99.1M -10.5% | -$233.2M -31.2% | -$92.8M -11.6% | $22.7M 3.2% | -$8.0M -1.6% | -$16.7M -4.6% | -$44.6M -24.3% | -$62.9M -58.5% | -$78.1M -92.6% |
| Interest Expense | $7.9M 0.8% | $7.4M 0.8% | $9.9M 1.3% | $6.2M 0.8% | — | — | — | — | — | — |
| Other Income (Expense), net | -$13.0M -1.3% | $7.3M 0.8% | $13.0M 1.7% | -$4K -0.0% | -$6.8M -1.0% | -$28.3M -5.7% | -$7.9M -2.2% | -$77.9M -42.4% | -$10.1M -9.4% | -$5.4M -6.4% |
| Pretax Income | -$200.3M -19.7% | -$91.9M -9.8% | -$220.3M -29.5% | -$92.9M -11.6% | $15.9M 2.3% | -$36.3M -7.3% | -$24.6M -6.8% | -$122.6M -66.7% | -$73.0M -67.9% | -$83.5M -99.1% |
| Income Tax Expense | $4.4M 0.4% | $4.2M 0.4% | $2.4M 0.3% | $1.7M 0.2% | $335K 0.0% | -$1.9M -0.4% | $149K 0.0% | $51K 0.0% | $8K 0.0% | -$15K -0.0% |
| Net Income | -$204.7M -20.2% | -$96.0M -10.2% | -$222.6M -29.8% | -$94.6M -11.8% | $15.6M 2.2% | -$34.4M -6.9% | -$24.8M -6.8% | -$122.6M -66.7% | -$73.0M -67.9% | -$83.4M -99.0% |
| Per Share | ||||||||||
| EPS (Basic) | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.25 | $-0.56 | $-0.42 | — | — | — |
| EPS (Diluted) | $-3.04 | $-1.47 | $-3.43 | $-1.47 | $0.24 | $-0.56 | $-0.42 | — | — | — |
| Weighted Avg Shares (Basic) | 67.3M | 65.5M | 65.0M | 64.1M | 63.0M | 61.0M | 58.5M | — | — | — |
| Weighted Avg Shares (Diluted) | 67.3M | 65.5M | 65.0M | 64.1M | 64.3M | 61.0M | 58.5M | — | — | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $17.23 today, the market must believe free cash flow compounds 45.1%/yr for a decade (off $5M normalized FCF).
2-stage DCF · 0.07B shares · net debt $219M
mean -336.9% · volatility σ 293% · implied rate exceeded in 0/4 yrs
Central path = implied 45.1%/yr growth; shaded band = ±1σ (293%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$30M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.20T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.02T | 49.6× | — | 15.7× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $916.2B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $643.4B | 24.2× | — | 6.8× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $464.4B | 111.2× | 33.2× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $362.6B | 19.9× | — | 5.6× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $340.0B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $252.6B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $244.5B | 36.5× | 31.5× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $202.8B | 26.4× | 17.4× | 5.5× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $183.3B | 21.8× | 20.0× | 6.2× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.2B | 27.5× | 19.3× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $156.1B | 20.2× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $147.3B | 41.3× | 30.5× | 6.0× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $135.8B | 48.6× | 37.3× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $130.4B | 33.5× | 28.6× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $129.4B | 18.4× | — | 2.7× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.5B | 24.8× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| LGVN | $117.4B | — | — | 97924.4× | -49.9% | 67.0% | -1894% | -400% | -400% | — | 31 |
| CVS | $116.6B | 66.0× | 11.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $108.8B | 33.9× | 18.7× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $103.4B | 23.1× | 16.3× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.7B | 15.2× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.1B | 16.4× | 15.4× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $81.0B | 18.7× | 19.4× | 5.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| TNDM | $1.2B | — | — | 1.2× | 7.9% | 53.8% | -20.2% | -132% | -44.0% | -1.8× | 263 |
Peers = companies sharing TNDM's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
Where each multiple sits in its own 13-yr range · 16th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 13-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 11.2× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 51.1 | 46.4 | 47.8 | 46.5 | 48.5 | 50.8 | 47.9 | 46.2 |
| Gross Profit | 48.9 | 53.6 | 52.2 | 53.5 | 51.5 | 49.2 | 52.1 | 53.8 |
| R&D | 15.9 | 12.5 | 12.7 | 13.1 | — | — | — | — |
| SG&A | 57.2 | 45.7 | 41.1 | 37.2 | 41.9 | 47.1 | 41.5 | 43.9 |
| Operating Income | -24.3 | -4.6 | -1.6 | 3.2 | -11.6 | -31.2 | -10.5 | -18.5 |
| Income Tax | 0.0 | 0.0 | -0.4 | 0.0 | 0.2 | 0.3 | 0.4 | 0.4 |
| Net Income | -66.7 | -6.8 | -6.9 | 2.2 | -11.8 | -29.8 | -10.2 | -20.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TNDM: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.